Back to top
more

Thermo Fisher Scientific (TMO)

(Delayed Data from NYSE)

$596.92 USD

596.92
2,138,161

+3.13 (0.53%)

Updated Oct 11, 2024 04:00 PM ET

After-Market: $596.52 -0.40 (-0.07%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth D Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 38% (96 out of 250)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

DENTSPLY SIRONA Strong on Deal Renewals, Forex Woes Stay

DENTSPLY SIRONA's (XRAY) renewed distribution deal will aid the company to gain market traction. However, forex woes remain a concern.

    Henry Schein Closes Merritt Buyout, Expands in Animal Health

    Henry Schein (HSIC) is consistently trying to expand its Animal Health business.

      CryoLife to Buy JOTEC, Preliminary Revenue Result Out for Q3

      CryoLife (CRY) gained access to the $2-billion global market for stent grafts through JOTEC deal.

        Mazor Projects Higher Q3 Revenues, Clinches Mazor X Orders

        Mazor's (MZOR) strong booking and order backlog from Mazor X system sales is likely to boost fortunes in the global spine surgery space.

          QIAGEN Banks on Tie-Ups & Product Launches, Competition Rife

          The market is upbeat about QIAGEN's (QGEN) partnership and co-marketing agreement with CENTOGENE AG to boost its bioinformatics portfolio.

            Express Scripts (ESRX) to Buy eviCore, Fortify PBM Business

            Express Scripts (ESRX) is consistently trying to expand its core PBM business.

              Pacific Biosciences, Bluebee Team Up for De Novo Sequencing

              With increasing demand for SMRT sequencing in the genomics community, both Pacific Biosciences (PACB) and partner Bluebee expect a huge customer adoption of integrated de novo assembly pipeline.

                QIAGEN Partners With CENTOGENE, Boosts Bioinformatics Suite

                QIAGEN (QGEN) makes another encouraging move to expand its advanced bioinformatics portfolio and add additional capabilities, partners CENTOGENE.

                  Illumina (ILMN) Strong on Product Launches, Competition Rife

                  Illumina rides high on product launches, including the latest release of VeriSeq NIPT in Europe, and strong uptake of NovaSeq. Weak margins remain a concern.

                    Boston Scientific Grows on New Products, Currency Woe Ails

                    Boston Scientific (BSX) is gaining traction on product launch and accretive acquisitions. Yet an unfavorable currency movement is a major dampener.

                      Hurricane Maria to Hurt Medtronic in Q2, FY18 View Intact

                      Medtronic (MDT) expects normal manufacturing process in Puerto Rico to resume in full force in the coming weeks with considerable repairing done in the aftermath of Hurricane Maria.

                        The Zacks Analyst Blog Highlights: Thermo Fisher Scientific, SeaSpine Holdings and EnteroMedics

                        The Zacks Analyst Blog Highlights: Thermo Fisher Scientific, SeaSpine Holdings and EnteroMedics

                          Integra's (IART) Revize/Revize-X Boosts Tissue Technology Arm

                          Integra (IART) widens its tissue technology segment with the launch of Revize/Revize-X Collagen Matrix for plastic and reconstructive surgery.

                            4 Momentum Stocks That May Survive the Health Policy Mess

                            In view of the current political scenario and banking on favorable metrics, these four MedTech stocks stand out as the most suitable momentum picks.

                              VWR's New Kitting Center in Czech Republic to Boost EMEA Arm

                              VWR's new strategically located 35,000 square foot facility in Skalice, Czech Republic looks to drive the company's business growth in the high-prospect EMEA region.

                                Bio-Techne's New Simple Plex Cartridge Boosts Protein Segment

                                Bio-Techne (TECH) introduces a multi-analyte cartridge format for the Ella immunoassay platform. The cartridge provides more accurate results at a lower cost.

                                  Thermo Fisher Fundamentals Impressive Amid Tough Competition

                                  Thermo Fisher (TMO) continues to gain considerable synergies from FEI acquisition. A raised guidance buoys optimism.

                                    Swarup Gupta headshot

                                    S&P 500 Nears 2,500: 5 Stock Picks for Big Profits

                                    The index has nearly always gained in the one-year period immediately following this winning streak.

                                      The Zacks Analyst Blog Highlights: Comcast, Thermo Fisher, China Life Insurance, Deere and American Airlines

                                      The Zacks Analyst Blog Highlights: Comcast, Thermo Fisher, China Life Insurance, Deere and American Airlines

                                        8 Factors That Make Thermo Fisher a Valuable Pick Right Now

                                        Based on a wide range of fundamental factors, Thermo Fisher (TMO) is a great pick for now.

                                          Mark Vickery headshot

                                          Top Research Reports for Comcast, Thermo Fisher & China Life Insurance

                                          Today's Research Daily features new research reports on 16 major stocks, including Comcast (CMCSA), Thermo Fisher (TMO), and China Life Insurance (LFC).

                                            Thermo Fisher Acquires Patheon, Boosts Laboratory Products

                                            Thermo Fisher's (TMO) acquisition of Patheon significantly strengthens its Pharmaceutical and Biotech business by adding complementary services.

                                              Luminex Partners Sutter Health to Boost Molecular Testing

                                              The latest development is a significant addition to Luminex's (LMNX) molecular testing and diagnostic portfolio. The company has a broad product portfolio that comprises the advanced ARIES platform.

                                                Thermo Fisher (TMO) Up 1.9% Since Earnings Report: Can It Continue?

                                                Thermo Fisher (TMO) reported earnings about a month ago. What's next for the company? We take a look at earnings estimates for some clues.

                                                  Agilent (A) Sues Former Employees for Infringing IP Rights

                                                  Agilent Technologies has sued its former employees who formed Shanghai Echrom Electronic Technology Co.